DJ Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slid 2.88% to $146.64 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.58% to 7,673.52 and Dow Jones Industrial Average falling 1.18% to 52,786.07.
This was the stock's second consecutive day of losses.
Gilead Sciences Inc. closed 6.77% below its 52-week high of $157.29, which the company reached on February 11th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 2.22% to $269.12, Pfizer Inc. $(PFE)$ fell 2.32% to $27.79, and Abbott Laboratories $(ABT)$ fell 2.59% to $105.52.
Trading volume (6.0 M) remained 673,543 below its 50-day average volume of 6.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.